Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 31

1.

Immunogenicity and safety of pandemic influenza A (H1N1) 2009 vaccine: systematic review and meta-analysis.

Yin JK, Khandaker G, Rashid H, Heron L, Ridda I, Booy R.

Influenza Other Respir Viruses. 2011 Sep;5(5):299-305. doi: 10.1111/j.1750-2659.2011.00229.x. Epub 2011 Mar 21. Review.

2.

Narcolepsy, 2009 A(H1N1) pandemic influenza, and pandemic influenza vaccinations: what is known and unknown about the neurological disorder, the role for autoimmunity, and vaccine adjuvants.

Ahmed SS, Schur PH, MacDonald NE, Steinman L.

J Autoimmun. 2014 May;50:1-11. doi: 10.1016/j.jaut.2014.01.033. Epub 2014 Feb 19. Review.

3.

[Assessment of the MF59-adjuvanted pandemic influenza A/H1N1 vaccine. Systematic review of literature].

Ruiz-Aragón J, Grande Tejada AM, Márquez-Peláez S, Molina Linde JM, Yang R.

An Pediatr (Barc). 2013 Oct;79(4):208-17. doi: 10.1016/j.anpedi.2013.01.022. Epub 2013 Mar 13. Review. Spanish.

4.

Immunogenicity and safety of inactivated influenza vaccines in primed populations: a systematic literature review and meta-analysis.

Beyer WE, Nauta JJ, Palache AM, Giezeman KM, Osterhaus AD.

Vaccine. 2011 Aug 5;29(34):5785-92. doi: 10.1016/j.vaccine.2011.05.040. Epub 2011 May 30. Review.

PMID:
21624411
6.

Influenza virus vaccines: lessons from the 2009 H1N1 pandemic.

Broadbent AJ, Subbarao K.

Curr Opin Virol. 2011 Oct;1(4):254-62. doi: 10.1016/j.coviro.2011.08.002. Review.

7.

Monovalent inactivated split-virion AS03-adjuvanted pandemic influenza A (H1N1) vaccine.

Walker WT, Faust SN.

Expert Rev Vaccines. 2010 Dec;9(12):1385-98. doi: 10.1586/erv.10.141. Review.

PMID:
21105775
8.

Key points in evaluating immunogenicity of pandemic influenza vaccines: A lesson from immunogenicity studies of influenza A(H1N1)pdm09 vaccine.

Ohfuji S, Kobayashi M, Ide Y, Egawa Y, Saito T, Kondo K, Ito K, Kase T, Maeda A, Fukushima W, Hirota Y.

Vaccine. 2017 Sep 18;35(39):5303-5308. doi: 10.1016/j.vaccine.2017.07.092. Epub 2017 Aug 4. Review.

9.

Is Systemic Lupus Erythematosus Associated With a Declined Immunogenicity and Poor Safety of Influenza Vaccination?: A Systematic Review and Meta-Analysis.

Huang Y, Wang H, Wan L, Lu X, Tam WW.

Medicine (Baltimore). 2016 May;95(19):e3637. doi: 10.1097/MD.0000000000003637. Review.

10.

Effectiveness of 2009 pandemic influenza A(H1N1) vaccines: A systematic review and meta-analysis.

Lansbury LE, Smith S, Beyer W, Karamehic E, Pasic-Juhas E, Sikira H, Mateus A, Oshitani H, Zhao H, Beck CR, Nguyen-Van-Tam JS.

Vaccine. 2017 Apr 11;35(16):1996-2006. doi: 10.1016/j.vaccine.2017.02.059. Epub 2017 Mar 14. Review.

11.

Inactivated influenza vaccines: recent progress and implications for the elderly.

Parodi V, de Florentiis D, Martini M, Ansaldi F.

Drugs Aging. 2011 Feb 1;28(2):93-106. doi: 10.2165/11586770-000000000-00000. Review.

PMID:
21275435
12.

Efficacy and safety of high-dose influenza vaccine in elderly adults: A systematic review and meta-analysis.

Wilkinson K, Wei Y, Szwajcer A, Rabbani R, Zarychanski R, Abou-Setta AM, Mahmud SM.

Vaccine. 2017 May 15;35(21):2775-2780. doi: 10.1016/j.vaccine.2017.03.092. Epub 2017 Apr 18. Review.

PMID:
28431815
13.

[Guillain-Barré syndrome after exposure to influenza].

Hartung HP, Keller-Stanislawski B, Hughes RA, Lehmann HC.

Nervenarzt. 2012 Jun;83(6):714-30. doi: 10.1007/s00115-012-3479-8. Review. German.

PMID:
22528062
14.

Effectiveness and harms of seasonal and pandemic influenza vaccines in children, adults and elderly: a critical review and re-analysis of 15 meta-analyses.

Manzoli L, Ioannidis JP, Flacco ME, De Vito C, Villari P.

Hum Vaccin Immunother. 2012 Jul;8(7):851-62. doi: 10.4161/hv.19917. Epub 2012 Jul 1. Review.

15.

Is rheumatoid arthritis associated with reduced immunogenicity of the influenza vaccination? A systematic review and meta-analysis.

Huang Y, Wang H, Tam WWS.

Curr Med Res Opin. 2017 Oct;33(10):1901-1908. doi: 10.1080/03007995.2017.1329140. Epub 2017 Jun 7. Review.

PMID:
28489423
16.

Immunogenicity and impact on disease activity of influenza and pneumococcal vaccines in systemic lupus erythematosus: a systematic literature review and meta-analysis.

Pugès M, Biscay P, Barnetche T, Truchetet MÉ, Richez C, Seneschal J, Gensous N, Lazaro E, Duffau P.

Rheumatology (Oxford). 2016 Sep;55(9):1664-72. doi: 10.1093/rheumatology/kew211. Epub 2016 May 9. Review.

PMID:
27160278
17.

Attack rates assessment of the 2009 pandemic H1N1 influenza A in children and their contacts: a systematic review and meta-analysis.

Glatman-Freedman A, Portelli I, Jacobs SK, Mathew JI, Slutzman JE, Goldfrank LR, Smith SW.

PLoS One. 2012;7(11):e50228. doi: 10.1371/journal.pone.0050228. Epub 2012 Nov 30. Review.

18.

Neurological events related to influenza A (H1N1) pdm09.

Cárdenas G, Soto-Hernández JL, Díaz-Alba A, Ugalde Y, Mérida-Puga J, Rosetti M, Sciutto E.

Influenza Other Respir Viruses. 2014 May;8(3):339-46. doi: 10.1111/irv.12241. Review.

19.

The Occupational Risk of Influenza A (H1N1) Infection among Healthcare Personnel during the 2009 Pandemic: A Systematic Review and Meta-Analysis of Observational Studies.

Lietz J, Westermann C, Nienhaus A, Schablon A.

PLoS One. 2016 Aug 31;11(8):e0162061. doi: 10.1371/journal.pone.0162061. eCollection 2016. Review.

20.

Advances in novel influenza vaccines: a patent review.

Song JM.

J Microbiol. 2016 Jun;54(6):403-12. doi: 10.1007/s12275-016-6176-7. Epub 2016 May 27. Review.

PMID:
27225456

Supplemental Content

Support Center